Chemotherapy dose limits set by users of a computer order entry system

Hospital Pharmacy

Volumn 41, Issue 2, 2006, Pages 136-142

  DuBeshter, Brent ^a   Griggs, Jennifer ^a   Angel, Cynthia ^b   Loughner, John ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b NONE

Author keywords

Chemotherapy dose safety; Computerized order entry

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE MACROGOL; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOCETAXEL; DOXORUBICIN; ESTRAMUSTINE; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; MERCAPTOPURINE; METHOTREXATE; NAVELBINE; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TIOGUANINE; TOPOTECAN; TRASTUZUMAB; VINCRISTINE;

AUTOMATION; BODY SURFACE; CANCER CHEMOTHERAPY; COMPUTER PROGRAM; COMPUTERIZED ORDER ENTRY SYSTEM; DRUG DOSE REGIMEN; DRUG INFORMATION; ELECTRONIC MEDICAL RECORD; HOSPITAL PHARMACY; HUMAN; INFORMATION PROCESSING; INTERNET; MALIGNANT NEOPLASTIC DISEASE; MEDICATION ERROR; PRESCRIPTION; REVIEW;

EID: 33644557751     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1310/hpj4102-136     Document Type: Review

References (15)

1. Schulmeister L. Chemetherapy medication erros: severity and contributing factors. Oncol Nurs Forum. 1999;26:1033-1042.
2. Harvard Medical Practice Study. Patients, Doctors and Lawyers: Studies of Medical Injury in New York. Boston, MA: Harvard University; 1990.
3. Cohen MR, Anderson RW, Atiilio RM, Green L, Muller RJ, Pruemer JM. Preventing medication errors in cancer chemotherapy. Am J of Health-Syst Pharm. 1996;53:737-746.
4. Opfer KB, Wirtz DM, Farley K. A chemotherapy standard order form: preventing errors. Oncol Nurs Forum. 1999;26:123-128.
5. Fischer DS, Alfano S, Knobf T, Donovan C, Beaulieu N. Improving the cancer chemotherapy use process. J Clin Oncol. 1996;14:3148-3155.
6. Bates DW, Leape LL, Cullen DJ. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311-1316.
7. ISMP Medication Safety Alert. Important error prevention advisory - cisplatin overdose. Available at: http://www.ismp.org/msaarticles/cisplatin2. html. Accessed on December 15, 2005.
8. Wachter RW, Shojania KG. Internal Bleeding: the truth behind America's terrifying epidemic of medical mistakes. 1st ed, New York, NY: Rugged Land; 2004.
9. Reduce ADEs involving chemotherapy: set dose limits for chemotherapy drugs. Available at: http://www.ihi.org/IHI/Topics/PatientSafety/ MedicationSystems. Accessed on July 20, 2004.
10. ISMP Medication Safety Alert. Over-reliance on pharmacy computer systems may place patients at great risk. Available at: http://www.ismp.org/msaarticles/ computer.html. Accessed on December 15, 2005.
11. DuBeshter, B. and Walsh, JW. Automated management of chemotherapy patients using IntelliDose: improved efficiency and error free dosing. Available at: http://www.asco.org/ac/1,1003,_12-002636-00_18-0017-00_19-0014985,00.asp. Accessed on December 15, 2005.
12. Baker SD, Grochow LB, Donehower RC. Should anticancer drug doses be adjusted in the obese patient? J Natl Cancer Inst. 1995;87:333-334.
13. Rosner GL, Hargis JB, Hollis Dr. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol. 1996;14:3000-3008.
14. Chemo overdose result of illegible prescription. The San Francisco Examiner. Available at: http:/www.sfexaminer. com/articles/2005/04/27/peninsula. Accessed on April 22, 2005.
15. Bates DW, Gawande AA, Improving safety with information technology: N Engl J Med. 2003;348:2526-2534.